Gregory Norden
Independent DirectorMr. Gregory Norden, also known as Greg, is Director of Uniquity Bio, Inc. Mr. Norden has been the Managing Director of G9 Capital Group LLC since October 2010. He has been an Independent Director of NS Wind Down Co., Inc. (formerly known as NanoString Technologies, Inc.), since July 2012. He has been an Independent Director at Praxis Precision Medicines, Inc. since March 2019 and Anthos Therapeutics, Inc. since December 2019. He started his career with Arthur Andersen & Company working with multinational public and private companies in the life sciences, financial services and consumer packaged goods industries. Mr. Norden served as Director at Entasis Therapeutics Holdings Inc from October 2016 to 2020. Mr. Norden served as the Chief Financial Officer and Senior Vice President of Wyeth, LLC from June 2007 to 2010 and served as its Principal Accounting Officer. He served as an Executive Vice President and Chief Financial Officer of Wyeth Pharmaceuticals since 2000. He joined Wyeth in 1989. He served as a Senior Vice President of Finance and Chief Financial Officer of American Home Food Products. He served as Senior Vice President and Chief Financial Officer of Wyeth, LLC. He held various senior positions with Wyeth/American Home Products from 1989 to 2010 including most recently as Chief Financial Officer. Prior to his affiliation with Wyeth, LLC, he served as Audit Manager at Arthur Andersen & Company. Mr. Norden has leadership experience in financial management and experience in global healthcare and pharmaceuticals. He served as the Chairman at Welch Allyn, Inc. Mr. Norden has been Director at Entasis Therapeutics Inc. since November 29, 2016. He has been an Independent Director of Zoetis Inc. since January 2013. Mr. Norden serves as Independent Director of Royalty Pharma Plc since June 7, 2020. He serves as Director at Univision Holdings, Inc. He had been a Director at Univision Communications Inc. since December 2015. He serves on the Board of Directors of KV Pharmaceutical. He served as a Director at Transportation 100 Holdco, LLC. He served as a Director of Human Genome Sciences Inc., from 2011 to 2012. He served as Director at Welch Allyn, Inc since February 2011 until September 2015. He served as Director at Lumara Health, Inc. from October 2013 to November 2014. He has been licensed as a certified public accountant by the state of New York since 1984. Mr. Norden Received an M.S. in Accounting from Long Island University, C.W. Post and B.S. in Management/Economics from the State University of New York, Plattsburgh.
公司职务
- 公司名称Zoetis Inc.股票代码ZTS职务Independent Director共事同僚
- KCKristin C. PeckCEO & Director
- MBMichael Benedict McCAllisterIndependent Non-Executive Chairman
- RLRoxanne LaganoExecutive VP, General Counsel & Corporate Secretary
- WNWetteny N. JosephSpecial Advisor to the CEO
- RJRobert J. PolzerScientific Advisor
- JBJamie BrannanExecutive VP & Chief Commercial Officer
- FAFrank A. D'AmelioIndependent Director
- GNGregory NordenIndependent Director
- GDGavin D. K. HattersleyIndependent Director
- 公司名称Royalty Pharma plc股票代码RPRX职务Independent Director共事同僚
- PLPablo LegorretaFounder, Chairman of the Board & CEO
- TPTerrance P. CoyneExecutive VP & CFO
- CHChristopher HiteChairman of Partnering & Investments
- MJMarshall Jonathan UristHead of Research & Investments
- GBGreg Butz Executive Vice President of Partnering & Investments
- TWTed W. LoveLead Independent Director
- DCDavid Charles HodgsonIndependent Director
- BLBonnie L. BasslerIndependent Director
- 公司名称Praxis Precision Medicines, Inc.股票代码PRAX职务Independent Director共事同僚
- MSMarcio Silva De'SouzaPresident, CEO & Director
- DJDean Jonathan MitchellIndependent Chairman of the Board
- TETimothy Edwin KellyCFO & Treasurer
- ANAlex NemiroffGeneral Counsel & Secretary
- SPSteven PetrouCo-Founder and President of Research & Development
- MTMegan T. SniecinskiChief Operating Officer
- WDWilliam Douglas YoungIndependent Director
- GNGregory NordenIndependent Director
- JAJeffrey Allan ChodakewitzIndependent Director
